JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1676
PUT
Boston Scientific
BSX
$61.4B
| $29.3M | ﹤0.01% |
327,900
-5,000
| -2% | -$440K |
2023 Q2
6 quarters
|
|
1677
NewMarket
NEU
$8.5B
| $29.3M | ﹤0.01% |
55,382
+4,797
| +9% | +$2.57M |
2013 Q2
46 quarters
|
|
1678
TransUnion
TRU
$12.2B
| $29.3M | ﹤0.01% |
315,530
+87,340
| +38% | +$8.85M |
2016 Q1
35 quarters
|
|
1679
iShares China Large-Cap ETF
FXI
$3.9B
| $29.2M | ﹤0.01% |
959,683
+216,336
| +29% | +$6.82M |
2013 Q2
46 quarters
|
|
1680
Spire
SR
$4.58B
| $29.1M | ﹤0.01% |
428,701
+138,971
| +48% | +$9.31M |
2013 Q2
46 quarters
|
|
1681
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$4.07B
| $29M | ﹤0.01% |
1,310,910
+1,075,434
| +457% | +$26M |
2024 Q1
3 quarters
|
|
1682
Crown Holdings
CCK
$11.6B
| $29M | ﹤0.01% |
350,354
+16,078
| +5% | +$1.46M |
2013 Q2
46 quarters
|
|
1683
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
| $28.9M | ﹤0.01% |
610,086
+61,915
| +11% | +$2.96M |
2013 Q2
46 quarters
|
|
1684
Kadant
KAI
$3.15B
| $28.9M | ﹤0.01% |
83,717
+18,995
| +29% | +$6.89M |
2013 Q2
46 quarters
|
|
1685
iShares US Medical Devices ETF
IHI
$3.54B
| $28.9M | ﹤0.01% |
494,843
-707,551
| -59% | -$42.1M |
2015 Q4
36 quarters
|
|
1686
State Street Real Estate Select Sector SPDR ETF
XLRE
$7.59B
| $28.8M | ﹤0.01% |
708,690
-34,300
| -5% | -$1.48M |
2016 Q2
34 quarters
|
|
1687
Sterling Infrastructure
STRL
$16B
| $28.8M | ﹤0.01% |
170,709
+40,661
| +31% | +$7.02M |
2017 Q2
30 quarters
|
|
1688
Etsy
ETSY
$6.51B
| $28.7M | ﹤0.01% |
543,307
-198,322
| -27% | -$10.6M |
2015 Q4
36 quarters
|
|
1689
Carvana
CVNA
$45.9B
| $28.7M | ﹤0.01% |
706,085
-368,185
| -34% | -$16.5M |
2017 Q2
30 quarters
|
|
1690
Paymentus
PAY
$3.98B
| $28.7M | ﹤0.01% |
878,887
+169,237
| +24% | +$5.03M |
2021 Q2
14 quarters
|
|
1691
Axos Financial
AX
$5.02B
| $28.7M | ﹤0.01% |
410,590
+128,932
| +46% | +$9.41M |
2013 Q2
46 quarters
|
|
1692
Bank of N.T. Butterfield & Son
NTB
$2.3B
| $28.7M | ﹤0.01% |
784,260
-340,373
| -30% | -$12.7M |
2017 Q3
29 quarters
|
|
1693
Gold Fields
GFI
$31.8B
| $28.6M | ﹤0.01% |
2,168,958
-369,580
| -15% | -$5.63M |
2013 Q2
46 quarters
|
|
1694
Immunovant
IMVT
$6.87B
| $28.6M | ﹤0.01% |
1,153,338
+925,081
| +405% | +$26.2M |
2020 Q1
19 quarters
|
|
1695
SS&C Technologies
SSNC
$18.6B
| $28.6M | ﹤0.01% |
376,904
-119,406
| -24% | -$8.93M |
2015 Q3
37 quarters
|
|
1696
Enphase Energy
ENPH
$4.42B
| $28.4M | ﹤0.01% |
414,081
-841,205
| -67% | -$66.8M |
2018 Q2
26 quarters
|
|
1697
Lumen
LUMN
$5.8B
| $28.4M | ﹤0.01% |
5,354,572
+1,953,534
| +57% | +$13.5M |
2013 Q2
46 quarters
|
|
1698
Sony
SONY
$138B
| $28.4M | ﹤0.01% |
1,343,421
-398,924
| -23% | -$7.77M |
2013 Q2
46 quarters
|
|
1699
Churchill Downs
CHDN
$5.41B
| $28.4M | ﹤0.01% |
212,663
+29,069
| +16% | +$4.03M |
2013 Q2
46 quarters
|
|
1700
PUT
DuPont de Nemours
DD
$17.6B
| $28.4M | ﹤0.01% |
296,679
+47,800
| +19% | +$4.97M |
2021 Q3
13 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.